NEW DELHI, Jan 3 (Reuters) - India's drugs regulator said on Sunday it had given final emergency-use approval for two coronavirus vaccines, one developed by AstraZeneca and Oxford University and the other by local company Bharat Biotech. (Reporting by Aftab Ahmed and Nigam Prusty: Editing by Neil Fullick)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5,334 INR | +1.23% | +0.86% | -3.37% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
12,026 GBX | +5.94% | +10.72% | 219B | ||
951.2 INR | +1.90% | +0.68% | 11.27B | ||
1st Jan change | Capi. | |
---|---|---|
-3.37% | 1.58B | |
+24.17% | 562B | |
-6.33% | 358B | |
+19.90% | 322B | |
+7.95% | 297B | |
+13.45% | 219B | |
+6.04% | 199B | |
-10.51% | 196B | |
-12.26% | 149B | |
-6.47% | 146B |
- Stock Market
- Equities
- ASTRAZEN Stock
- News AstraZeneca Pharma India Limited
- AstraZeneca Pharma India : India gives final urgent-use approval to AstraZeneca, local COVID vaccines